Publications

AbYlink afabicin (Debio 1450) afabicin (Debio 1450) ABSSSI afabicin (Debio 1450) Bone & joint infections CPP cyclosporin A Debio 0123 Debio 0228 Debio 025 Debio 0614 (istaroxime) Debio 0719 Debio 0932 NSCLS Debio 1124 Debio 1143 Debio 1143 Head & neck cancer Debio 1143 NSCLC Debio 1143 Ovarian cancer Debio 1347 Debio 1452 Debio 1561 Debio 1562 Debio 4126 Debio 8609 Sanvar Debio 9902 - ZT-1 EPI-hNE4 FibroTrap fuze Heparins Huperzine-A Multilink naratuximab emtansine (Debio 1562) Oxaliplatin PLGA Triptorelin

December 30, 2000

A Crossover Study of Triptorelin and Leuprorelin Acetate

August 18, 2000

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

March 18, 2000

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for…

November 30, 1999

Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results…

June 15, 1999

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic…

May 30, 1999

Effectiveness and Tolerance of one dosage form (subcutaneous and intramuscular) of Decapeptyl depot in patients with advanced prostate carcinoma

February 15, 1992

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor…